Sphingotec GmbHPartnershipSphingotec licenses kidney function testGerman diagnostics company Sphingotec GmbH has licensed its real-time kidney function test to US diagnostics giant Beckman Coulter allowing it to expand its business to the US as announced earlier this … more ➔
Astellas Pharma IncLicence dealAviadoBio Ltd inks US$2.2bn gene therapy d...AviadoBio Ltd has cashed in €30m upfront and €20m as an equity investment from Astellas Pharma Inc for signing a licence option agreement for its Phase I/II gene therapy programme AVR-01. more ➔
AI via FreepikFinancingVicore secures funding to accelerate drug...Swedish clinical-stage pharmaceutical company Vicore Pharma has secured SEK100m, supported by existing and new investors. The injection of capital will allow the company to scale the clinical development … more ➔
EIBFinancing€20m loan for pandemic preparednessFab’entech, a French biopharma company, has secured a loan worth €20m from the European Investment Bank (EIB) under the HERA Invest programme, aimed at bolstering Europe’s preparedness against biological … more ➔
MoneyKurma closes new fund at €250mKurma Partners announced a first closing of its new Biofund IV at €140m targeted to raise €250m to finance 16-20 life science companies. more ➔
https://doi.org/10.3390/ijms241411791Breast CancerGenentech takes over Regor’s RGT-419...Genentech, the US subsidiary of Swiss pharmaceutical giant Roche AG, has strengthened the company’s breast cancer pipeline by pre-licensing the global commercialisation rights to Regor Therapeutics’ … more ➔
Spima TherapeuticsPartnershipSpima Therapeutics starts with global lice...SPIMA Therapeutics SA lauches with €1m investment by SATT AxLR, which has licenced the company’s lead programme, SP-001 more ➔
GourmeyNovel FoodEFSA updates guidelines on cultured protei...The EU’s food watchdog EFSA has updated its guidelines for novel food applications including cell-based and fermented foods to streamline approval times and clarify that food safety is its highest priority … more ➔
Ovid Therapeutics - Jeremy LevinStatementLong version of The BIOSECURE Act: The Wes...By Jeremy Levin, D.Phil, MB BChir more ➔
Asabys PartnersFinancingAsabys Partners close €180m Sabadell Asa...Asabys Partners have announced the closing of a new oversubscribed fund aimed at investing in 12-15 companies across all areas of pharma biotech. more ➔
Sphingotec GmbH
Astellas Pharma Inc
AI via Freepik
EIB
https://doi.org/10.3390/ijms241411791
Spima Therapeutics
Gourmey
Ovid Therapeutics - Jeremy Levin
Asabys Partners